{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:54:54Z","timestamp":1781513694215,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["252300420583"],"award-info":[{"award-number":["252300420583"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00210-026-05132-z","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T02:52:17Z","timestamp":1772419937000},"page":"12027-12036","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Schisandrin B targets CD44 to inhibit glioblastoma multiforme"],"prefix":"10.1007","volume":"399","author":[{"given":"Na","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenpei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"5132_CR1","doi-asserted-by":"publisher","unstructured":"Ando T, Yamasaki J, Saya H et al (2025) CD44: a key regulator of iron metabolism, redox balance, and therapeutic resistance in cancer stem cells. Stem Cells 43. https:\/\/doi.org\/10.1093\/stmcls\/sxaf024","DOI":"10.1093\/stmcls\/sxaf024"},{"key":"5132_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12017-024-08797-y","volume":"26","author":"K Bajdak-Rusinek","year":"2024","unstructured":"Bajdak-Rusinek K, Diak N, Gutmajster E et al (2024) The CD44s isoform is a potential biomarker for predicting craniopharyngioma recurrence in children. Neuromol Med 26:30. https:\/\/doi.org\/10.1007\/s12017-024-08797-y","journal-title":"Neuromol Med"},{"key":"5132_CR3","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1158\/0008-5472.Can-23-0510","volume":"83","author":"Y Bei","year":"2023","unstructured":"Bei Y, He J, Dong X et al (2023) Targeting CD44 variant 5 with an antibody-drug conjugate is an effective therapeutic strategy for intrahepatic cholangiocarcinoma. Cancer Res 83:2405\u20132420. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-0510","journal-title":"Cancer Res"},{"key":"5132_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-025-10070-2","volume":"41","author":"S Cai","year":"2025","unstructured":"Cai S, Chen Y, Chen C et al (2025) CD44-targeted therapy using mP6\/Rg3 micelles inhibits oral cancer stem cell proliferation and migration. Cell Biol Toxicol 41:122. https:\/\/doi.org\/10.1007\/s10565-025-10070-2","journal-title":"Cell Biol Toxicol"},{"key":"5132_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8029963","volume":"2021","author":"Y Chen","year":"2021","unstructured":"Chen Y, Kong Y, Wang Q et al (2021) Schisandrin B attenuates airway inflammation by regulating the NF-\u03baB\/Nrf2 signaling pathway in mouse models of asthma. J Immunol Res 2021:8029963. https:\/\/doi.org\/10.1155\/2021\/8029963","journal-title":"J Immunol Res"},{"key":"5132_CR6","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1016\/j.csbj.2022.09.003","volume":"20","author":"Z Du","year":"2022","unstructured":"Du Z, Wang Y, Liang J et al (2022) Association of glioma CD44 expression with glial dynamics in the tumour microenvironment and patient prognosis. Comput Struct Biotechnol J 20:5203\u20135217. https:\/\/doi.org\/10.1016\/j.csbj.2022.09.003","journal-title":"Comput Struct Biotechnol J"},{"key":"5132_CR7","doi-asserted-by":"publisher","unstructured":"Du T, Wu Z, Wu Y et al (2023) CD44 Is associated with poor prognosis of ccRCC and facilitates ccRCC cell migration and invasion through HAS1\/MMP9. Biomedicines 11. https:\/\/doi.org\/10.3390\/biomedicines11072077","DOI":"10.3390\/biomedicines11072077"},{"key":"5132_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.sdentj.2021.09.022","volume":"34","author":"AAM Essa","year":"2022","unstructured":"Essa AAM, Deraz EM (2022) Expression of CD44 (NKI-P1) in oral squamous cell carcinoma associated vascular endothelial cells: a relationship to tumor angiogenesis. Saudi Dent J 34:21\u201326. https:\/\/doi.org\/10.1016\/j.sdentj.2021.09.022","journal-title":"Saudi Dent J"},{"key":"5132_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-022-00386-z","volume":"9","author":"QL Guo","year":"2022","unstructured":"Guo QL, Dai XL, Yin MY et al (2022) Nanosensitizers for sonodynamic therapy for glioblastoma multiforme: current progress and future perspectives. Mil Med Res 9:26. https:\/\/doi.org\/10.1186\/s40779-022-00386-z","journal-title":"Mil Med Res"},{"key":"5132_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biom11121850","author":"M Hassn Mesrati","year":"2021","unstructured":"Hassn Mesrati M, Syafruddin SE, Mohtar MA et al (2021) CD44: a multifunctional mediator of cancer progression. Biomolecules. https:\/\/doi.org\/10.3390\/biom11121850","journal-title":"Biomolecules"},{"key":"5132_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174823","volume":"920","author":"L He","year":"2022","unstructured":"He L, Chen H, Qi Q et al (2022) Schisandrin B suppresses gastric cancer cell growth and enhances the efficacy of chemotherapy drug 5-FU in vitro and in vivo. Eur J Pharmacol 920:174823. https:\/\/doi.org\/10.1016\/j.ejphar.2022.174823","journal-title":"Eur J Pharmacol"},{"key":"5132_CR12","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/ptr.7644","volume":"37","author":"JN Hu","year":"2023","unstructured":"Hu JN, Wang YM, Zhang H et al (2023) Schisandra B, a representative lignan from Schisandra chinensis, improves cisplatin-induced toxicity: an in vitro study. Phytother Res 37:658\u2013671. https:\/\/doi.org\/10.1002\/ptr.7644","journal-title":"Phytother Res"},{"key":"5132_CR13","doi-asserted-by":"publisher","unstructured":"Inoue A, Ohnishi T, Nishikawa M et al (2023) A narrative review on CD44's role in Glioblastoma invasion, proliferation, and tumor recurrence. Cancers (Basel) 15. https:\/\/doi.org\/10.3390\/cancers15194898","DOI":"10.3390\/cancers15194898"},{"key":"5132_CR14","doi-asserted-by":"publisher","first-page":"19877","DOI":"10.1039\/d5cp01814e","volume":"27","author":"G Kaur","year":"2025","unstructured":"Kaur G, Goyal B (2025) Ligand-based virtual screening to discover potential inhibitors of SARS-CoV-2 main protease. Phys Chem Chem Phys 27:19877\u201319897. https:\/\/doi.org\/10.1039\/d5cp01814e","journal-title":"Phys Chem Chem Phys"},{"key":"5132_CR15","doi-asserted-by":"publisher","first-page":"036102","DOI":"10.1063\/5.0203028","volume":"8","author":"MD Kelly","year":"2024","unstructured":"Kelly MD, Pawlak MR, Zhan KH et al (2024) Mutual antagonism between CD44 and integrins in glioblastoma cell traction and migration. APL Bioeng 8:036102. https:\/\/doi.org\/10.1063\/5.0203028","journal-title":"APL Bioeng"},{"key":"5132_CR16","doi-asserted-by":"publisher","first-page":"800481","DOI":"10.3389\/fphar.2021.800481","volume":"12","author":"P Kesharwani","year":"2021","unstructured":"Kesharwani P, Chadar R, Sheikh A et al (2021) CD44-targeted nanocarrier for cancer therapy. Front Pharmacol 12:800481. https:\/\/doi.org\/10.3389\/fphar.2021.800481","journal-title":"Front Pharmacol"},{"key":"5132_CR18","doi-asserted-by":"publisher","unstructured":"Kolliopoulos C, Ali MM, Castillejo-Lopez C et al (2022) CD44 Depletion in glioblastoma cells suppresses growth and stemness and induces senescence. Cancers (Basel) 14. https:\/\/doi.org\/10.3390\/cancers14153747","DOI":"10.3390\/cancers14153747"},{"key":"5132_CR19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1158\/0008-5472.Can-19-1108","volume":"80","author":"T Kong","year":"2020","unstructured":"Kong T, Ahn R, Yang K et al (2020) CD44 promotes PD-L1 expression and its tumor-intrinsic function in breast and lung cancers. Cancer Res 80:444\u2013457. https:\/\/doi.org\/10.1158\/0008-5472.Can-19-1108","journal-title":"Cancer Res"},{"key":"5132_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.47717\/turkjsurg.2025.6837","volume":"41","author":"O Kostovski","year":"2025","unstructured":"Kostovski O, Jovanovikj R, Kostovska I (2025) Co-expression of stem cell markers CD133 and CD44 as predictors of metastatic potential of colorectal carcinoma. Turk J Surg 41:174\u2013179. https:\/\/doi.org\/10.47717\/turkjsurg.2025.6837","journal-title":"Turk J Surg"},{"key":"5132_CR21","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.3c03409","author":"X Li","year":"2023","unstructured":"Li X, Jiang F, Hu Y et al (2023) Schisandrin B promotes hepatic stellate cell ferroptosis via Wnt pathway-mediated Ly6C(lo) macrophages. J Agric Food Chem. https:\/\/doi.org\/10.1021\/acs.jafc.3c03409","journal-title":"J Agric Food Chem"},{"key":"5132_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.anireprosci.2025.107889","volume":"279","author":"C Li","year":"2025","unstructured":"Li C, Ji KB, Kim EY et al (2025) Schisandrin B mitigates oxidative damage in early porcine embryos exposed to Ochratoxin A via NRF2 pathway activation. Anim Reprod Sci 279:107889. https:\/\/doi.org\/10.1016\/j.anireprosci.2025.107889","journal-title":"Anim Reprod Sci"},{"key":"5132_CR23","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/1724600817746951","volume":"33","author":"Y Liu","year":"2018","unstructured":"Liu Y, Wu T, Lu D et al (2018) CD44 overexpression related to lymph node metastasis and poor prognosis of pancreatic cancer. Int J Biol Markers 33:308\u2013313. https:\/\/doi.org\/10.1177\/1724600817746951","journal-title":"Int J Biol Markers"},{"key":"5132_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1550961","volume":"15","author":"W Liu","year":"2025","unstructured":"Liu W, Xiong T, Sun H et al (2025) Human annexin A5 promotes glioma progression by targeting the MAPK\/CD44 pathway. Front Oncol 15:1550961. https:\/\/doi.org\/10.3389\/fonc.2025.1550961","journal-title":"Front Oncol"},{"key":"5132_CR25","first-page":"6926","volume":"8","author":"XJ Lv","year":"2015","unstructured":"Lv XJ, Zhao LJ, Hao YQ et al (2015) Schisandrin B inhibits the proliferation of human lung adenocarcinoma A549 cells by inducing cycle arrest and apoptosis. Int J Clin Exp Med 8:6926\u20136936","journal-title":"Int J Clin Exp Med"},{"key":"5132_CR26","first-page":"1397","volume":"51","author":"Q Ma","year":"2020","unstructured":"Ma Q, Liu C, Du H et al (2020) Virtual screening of small molecular inhibitors of SARS-CoV-2 3CL hydrolase based on high-throughput molecular docking and prediction of Chinese materia medica and its compound against COVID-19. Zhongguo Zhong Yao Za Zhi 51:1397\u20131405","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"5132_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/1735-5362.329928","volume":"17","author":"P Mahinfar","year":"2022","unstructured":"Mahinfar P, Mokhtarzadeh A, Baradaran B et al (2022) Antiproliferative activity of CD44 siRNA-PEI-PEG nanoparticles in glioblastoma: involvement of AKT signaling. Res Pharm Sci 17:78\u201385. https:\/\/doi.org\/10.4103\/1735-5362.329928","journal-title":"Res Pharm Sci"},{"key":"5132_CR28","doi-asserted-by":"publisher","unstructured":"Mihi\u0107 J, Rotim K, Vu\u010di\u0107 M et al (2019) Prognostic role of CD44 expression and neovascularization determined by endoglin (CD105) in glioblastoma patients. Acta Clin Croat 58:455\u2013462. https:\/\/doi.org\/10.20471\/acc.2019.58.03.08","DOI":"10.20471\/acc.2019.58.03.08"},{"key":"5132_CR29","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.5603\/RPOR.a2022.0113","volume":"27","author":"S Mohammed","year":"2022","unstructured":"Mohammed S, Dinesan M, Ajayakumar T (2022) Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study. Rep Pract Oncol Radiother 27:1026\u20131036. https:\/\/doi.org\/10.5603\/RPOR.a2022.0113","journal-title":"Rep Pract Oncol Radiother"},{"key":"5132_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1089\/nat.2019.0833","volume":"30","author":"A P\u0119cak","year":"2020","unstructured":"P\u0119cak A, Skalniak \u0141, Pels K et al (2020) Anti-CD44 DNA aptamers selectively target cancer cells. Nucleic Acid Ther 30:289\u2013298. https:\/\/doi.org\/10.1089\/nat.2019.0833","journal-title":"Nucleic Acid Ther"},{"key":"5132_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-89895-0","volume":"15","author":"M Shi","year":"2025","unstructured":"Shi M, Ning Z (2025) In vivo and in vitro investigations of schisandrin B against angiotensin II induced ferroptosis and atrial fibrosis by regulation of the SIRT1 pathway. Sci Rep 15:6200. https:\/\/doi.org\/10.1038\/s41598-025-89895-0","journal-title":"Sci Rep"},{"key":"5132_CR32","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2147\/cmar.S233423","volume":"12","author":"D Si","year":"2020","unstructured":"Si D, Yin F, Peng J et al (2020) High expression of CD44 predicts a poor prognosis in glioblastomas. Cancer Manag Res 12:769\u2013775. https:\/\/doi.org\/10.2147\/cmar.S233423","journal-title":"Cancer Manag Res"},{"key":"5132_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12070-022-03200-3","volume":"75","author":"B Singh","year":"2023","unstructured":"Singh B, Aggarwal S, Das P et al (2023) Over expression of cancer stem cell marker CD44 and its clinical significance in patients with oral squamous cell carcinoma. Indian J Otolaryngol Head Neck Surg 75:109\u2013114. https:\/\/doi.org\/10.1007\/s12070-022-03200-3","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"5132_CR34","doi-asserted-by":"publisher","first-page":"663092","DOI":"10.3389\/fncel.2021.663092","volume":"15","author":"JS So","year":"2021","unstructured":"So JS, Kim H, Han KS (2021) Mechanisms of invasion in glioblastoma: extracellular matrix, Ca(2+) signaling, and glutamate. Front Cell Neurosci 15:663092. https:\/\/doi.org\/10.3389\/fncel.2021.663092","journal-title":"Front Cell Neurosci"},{"key":"5132_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/ane.13625","volume":"146","author":"P St\u00e5hl","year":"2022","unstructured":"St\u00e5hl P, Henoch I, Smits A et al (2022) Quality of life in patients with glioblastoma and their relatives. Acta Neurol Scand 146:82\u201391. https:\/\/doi.org\/10.1111\/ane.13625","journal-title":"Acta Neurol Scand"},{"key":"5132_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102883","author":"SS Stylli","year":"2020","unstructured":"Stylli SS (2020) Novel treatment strategies for glioblastoma. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12102883","journal-title":"Cancers (Basel)"},{"key":"5132_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY et al (2020) Management of glioblastoma: state of the art and future directions. CA Cancer J Clin 70:299\u2013312. https:\/\/doi.org\/10.3322\/caac.21613","journal-title":"CA Cancer J Clin"},{"key":"5132_CR38","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1074\/jbc.M113.529313","volume":"289","author":"M Tsuneki","year":"2014","unstructured":"Tsuneki M, Madri JA (2014) CD44 regulation of endothelial cell proliferation and apoptosis via modulation of CD31 and VE-cadherin expression. J Biol Chem 289:5357\u20135370. https:\/\/doi.org\/10.1074\/jbc.M113.529313","journal-title":"J Biol Chem"},{"key":"5132_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1583307","volume":"16","author":"J Wan","year":"2025","unstructured":"Wan J, Lang C, Gao M et al (2025) Schisandrin B alleviates metabolic associated fatty liver disease by regulating the PPAR\u03b3 signaling pathway and gut microbiota in mice. Front Pharmacol 16:1583307. https:\/\/doi.org\/10.3389\/fphar.2025.1583307","journal-title":"Front Pharmacol"},{"key":"5132_CR40","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.2147\/ott.S247836","volume":"13","author":"H Wang","year":"2020","unstructured":"Wang H, Ye X, Ju Y et al (2020) Minicircle DNA-mediated CAR T cells targeting CD44 suppressed hepatocellular carcinoma both in vitro and in vivo. Onco Targets Ther 13:3703\u20133716. https:\/\/doi.org\/10.2147\/ott.S247836","journal-title":"Onco Targets Ther"},{"key":"5132_CR41","doi-asserted-by":"publisher","unstructured":"Wang Y, Chen J, Huang Y et al (2022) Schisandrin B suppresses osteosarcoma lung metastasis in vivo by inhibiting the activation of the Wnt\/\u03b2\u2011catenin and PI3K\/Akt signaling pathways. Oncol Rep 47. https:\/\/doi.org\/10.3892\/or.2022.8261","DOI":"10.3892\/or.2022.8261"},{"key":"5132_CR42","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1093\/neuonc\/noab011","volume":"23","author":"JS Wefel","year":"2021","unstructured":"Wefel JS, Armstrong TS, Pugh SL et al (2021) Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG\/RTOG 0825). Neuro Oncol 23:1125\u20131138. https:\/\/doi.org\/10.1093\/neuonc\/noab011","journal-title":"Neuro Oncol"},{"key":"5132_CR43","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","volume":"22","author":"PY Wen","year":"2020","unstructured":"Wen PY, Weller M, Lee EQ et al (2020) Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol 22:1073\u20131113. https:\/\/doi.org\/10.1093\/neuonc\/noaa106","journal-title":"Neuro Oncol"},{"key":"5132_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1139\/apnm-2018-0251","volume":"44","author":"Y Wu","year":"2018","unstructured":"Wu Y, Li Z-C, Yao L-Q et al (2018) Schisandrin B alleviates acute oxidative stress via modulation of the Nrf2\/Keap1-mediated antioxidant pathway. Appl Physiol Nutr Metab 44:1\u20136. https:\/\/doi.org\/10.1139\/apnm-2018-0251","journal-title":"Appl Physiol Nutr Metab"},{"key":"5132_CR45","doi-asserted-by":"publisher","unstructured":"Wu G, Song X, Liu J et al (2020) Expression of CD44 and the survival in glioma: a meta-analysis. Biosci Rep 40. https:\/\/doi.org\/10.1042\/bsr20200520","DOI":"10.1042\/bsr20200520"},{"key":"5132_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202500424","volume":"22","author":"E Yadav","year":"2025","unstructured":"Yadav E, Yadav PK (2025) Insights into anticancer mechanisms of Schisandrin B: isolation, pharmacokinetics, and preclinical evidence. Chem Biodivers 22:e00424. https:\/\/doi.org\/10.1002\/cbdv.202500424","journal-title":"Chem Biodivers"},{"key":"5132_CR47","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-6109","volume":"8","author":"C Yan","year":"2020","unstructured":"Yan C, Gao L, Qiu X et al (2020) Schisandrin B synergizes docetaxel-induced restriction of growth and invasion of cervical cancer cells in vitro and in vivo. Ann Transl Med 8:1157. https:\/\/doi.org\/10.21037\/atm-20-6109","journal-title":"Ann Transl Med"},{"key":"5132_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70158","volume":"169","author":"X Yang","year":"2025","unstructured":"Yang X, Wang S, Montana V et al (2025) Status and prospects of glioblastoma multiforme treatments. J Neurochem 169:e70158. https:\/\/doi.org\/10.1111\/jnc.70158","journal-title":"J Neurochem"},{"key":"5132_CR49","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1440-1827.2012.02823.x","volume":"62","author":"T Yoshida","year":"2012","unstructured":"Yoshida T, Matsuda Y, Naito Z et al (2012) CD44 in human glioma correlates with histopathological grade and cell migration. Pathol Int 62:463\u2013470. https:\/\/doi.org\/10.1111\/j.1440-1827.2012.02823.x","journal-title":"Pathol Int"},{"key":"5132_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03748-4","volume":"25","author":"YJ Zhu","year":"2025","unstructured":"Zhu YJ, Li SY, Yang SS et al (2025) CD44 on cancer stem cell is a potential immunological and prognostic pan-cancer biomarker. Cancer Cell Int 25:134. https:\/\/doi.org\/10.1186\/s12935-025-03748-4","journal-title":"Cancer Cell Int"},{"key":"5132_CR51","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.17305\/bb.2025.11791","volume":"25","author":"A Zottel","year":"2025","unstructured":"Zottel A, \u0160amec N, Jov\u010devska I (2025) TNFSF14 and CD44 are overexpressed in glioblastoma and associated with immunosuppressive microenvironment. Biomol Biomed 25:1829\u20131843. https:\/\/doi.org\/10.17305\/bb.2025.11791","journal-title":"Biomol Biomed"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05132-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05132-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05132-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:18:50Z","timestamp":1781511530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05132-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5132"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05132-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The author requested an update of the first author\u2019s (Na Wang) affiliation to the correct format.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The operational procedure was carried out in strict compliance with the regulations set forth by the Animal Ethics Committee of Henan University (Permit Number: HUSOM2024-067).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to the publication of this work in Naunyn\u2013Schmiedeberg's Archives of Pharmacology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}